Stock IRME IR-MED INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials IR-Med Inc.

Equities

IRME

US46265R1032

Medical Equipment, Supplies & Distribution

Delayed OTC Markets
Other stock markets
 01:19:55 17/05/2024 am IST 		5-day change 1st Jan Change
0.6412 USD -24.56% Intraday chart for IR-Med Inc. -28.74% -44.23%
05/04 IR-Med Inc.'S PressureSafe Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries CI
01/04 IR-Med Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 34.4 80.42 44.87 -
Enterprise Value (EV) 1 34.4 80.42 44.87 44.87
P/E ratio -7.14 x -16.4 x -12.8 x 21.4 x
Yield - - - -
Capitalization / Revenue - - 44.9 x 4.85 x
EV / Revenue - - 44.9 x 4.85 x
EV / EBITDA - -16.4 x -13.8 x 19.7 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - - - -
Nbr of stocks (in thousands) 68,809 69,931 69,975 -
Reference price 2 0.5000 1.150 0.6412 0.6412
Announcement Date 29/03/23 01/04/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - - 1 9.25
EBITDA 1 - -4.894 -3.262 2.277
EBIT 1 - -4.911 -3.258 2.28
Operating Margin - - -325.78% 24.65%
Earnings before Tax (EBT) 1 - -4.909 -3.258 2.265
Net income 1 -4.734 -4.909 -3.258 1.925
Net margin - - -325.78% 20.81%
EPS 2 -0.0700 -0.0700 -0.0500 0.0300
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 29/03/23 01/04/24 - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - 0.3 0.7
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS 2 -0.0200 -0.0200 -0.0100 -0.0100 -0.0100 -0.0200
Dividend per Share - - - - - -
Announcement Date 14/11/23 01/04/24 13/05/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - - - -
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share - - - -
Cash Flow per Share - - - -
Capex - - - -
Capex / Sales - - - -
Announcement Date 29/03/23 01/04/24 - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
IR-MED INC. Stock IR-Med Inc.
-44.23% 44.87M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.72% 182B
MEDTRONIC PLC Stock Medtronic plc
+3.96% 114B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-2.93% 68.38B
DEXCOM, INC. Stock DexCom, Inc.
+6.30% 52.46B
CENCORA, INC. Stock Cencora, Inc.
+8.02% 44.25B
HOYA CORPORATION Stock Hoya Corporation
+7.52% 43.55B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+26.18% 32.69B
TERUMO CORPORATION Stock Terumo Corporation
+17.85% 26.73B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.57% 25.79B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. IRME Stock
  4. Financials IR-Med Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW